Study of AD-234 drugs in healthy adults
Part of Digestive system clinical trials.
This trial tests three similar drugs to see how they are processed by the body and how safe they are. It is for healthy volunteers to help find the best dose and form of these medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 19 and 50 years old.
- Your weight is between 110 and 198 pounds (50 to 90 kg).
- Your body mass index (BMI) is between 18.5 and 29.9.
- If you are female, you are not pregnant, not breastfeeding, or have had surgery to prevent pregnancy.
- You have not been in another drug study in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how two versions of the study drug AD-229 are processed by the body and how safe they are in healthy volunteers.
This trial tests a new drug (AD-115A or AD-1151) in healthy volunteers to see how safe it is and how the body processes it. If you qualify, you'll receive a single dose and be monitored closely.
This study tests how two experimental drugs, called AD-236A and AD-236B, interact in the body and checks if they are safe. Healthy volunteers are needed to see how the drugs affect each other.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This early-stage study tests a new investigational drug called AD-231 to see how safe it is and how your body processes it. Researchers will compare it to a combination of three related drugs to understand which approach works best.
This trial studies how two experimental drugs (AD-2321 and AD-2322) interact in the body and if they are safe for healthy volunteers. It is a Phase 1 study open to healthy adults.
Hear when a new Gastritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.